Polaris AI Pharma Corp.
Manufactures over 60 active pharmaceutical ingredients at its Hwaseong plant as an API and CDMO specialist.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1998 and listed on KOSDAQ in 2004, Polaris AI Pharma is a pharmaceutical company specializing in active pharmaceutical ingredients (API) and CDMO. In 2025, of its KRW 55.5 billion in revenue, API accounted for 96.31% (KRW 53.5 billion: KRW 39.7 billion domestic, KRW 13.8 billion export) and CDMO for 3.69% (KRW 2.1 billion); it manufactures over 60 APIs at its Hwaseong plant, supplying more than 100 domestic and overseas clients. It completed a c-GMP plant in April 2008 and an expansion in November 2012, has self-developed numerous APIs including the new-drug CMO project PAC-14028, and holds multiple related patents in Korea, Japan, China, and elsewhere.
Products & technology
- Active pharmaceutical ingredients (API)Production of generic, new-drug, and improved-drug raw materials (60+ items)
- CDMOCustom development and production of pharmaceutical raw materials, intermediates, and formulations
R&D and key agreements
Source: DART corporate disclosurePAC-14028 · 신약 CMO 과제 · Self-developed new-drug CMO project
항응고제 계열 API(Apixaban, Edoxaban tosilate hydrate, Dabigatran etexilate 등) · 혈전·항응고 · 자체개발 완료 · Self-developed multiple anticoagulant APIs
특허 취득 APIs(두타스테리드·타다라필 복합정, 테노포비르 디소프록실 정제, 플루복사민 정제법 등) · 특허 취득완료 · Obtained related patents in Korea, Japan, China, and other countries
Companies in the same categoryPharma & CDMO
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition